Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
IDBank warns of scam calls impersonating pension fundsA little corner of France in Hrazdan, with the partnership of Converse SME Idram is the general partner of the "Towards Conscious Parenting 2026" annual conference Polytechnic University Graduation Ceremony Held with the Support of Unibank Converse Bank Completes the Placement of EBRD Bonds From Financial Adventures to Great Victories: The 4th Junius Financial Online Tournament Wrapped UpThe Power of One Dram and the Armenian State Symphony Orchestra Conclude the Forest Project Launched in Shirak EBRD to Launch AMD 5 Billion Floating-Rate Bond Offering in Armenia Three-day Financial Literacy Course at the FAST Foundation’s AI Camp: Idram&IDBank Coffee, a Break, and Up to 10% idcoin with Idram&IDBank Ucom Introduces the New uMix 5000 Regional Package: 3 Services for Just AMD 5,000 per Month "Monaco glamour, Vegas energy, Macau prestige - yet uniquely Armenian." Artak Tovmasyan on how Seven Visions is redefining world-class hospitality Travel Without Borders: Ucom Introduces New uTravel Packages Artur Nakhshikyan has joined the Supervisory Board of Unibank "Your smartphone is locked": IDBank warns of cyberextortion that turns your smartphone into a "brick" “From Classroom to Orbit”: With Ucom’s Support, “Space 1.0” Is Being Introduced in 15 Schools Across Armenia AraratBank Reports Growth in its SME Loan Portfolio in 2025 Converse Bank and ADB expand access to MSME and sustainable finance in ArmeniaUnibank and "Vanq" Charity Fund Support Wheelchair Basketball Exhibition Game in Yerevan Armenia’s Largest QR Payment Systems to Collaborate: ArcaQR – IdramNet
Life

Scientists figure out mechanism of brain damage by COVID-19

Scientists in the UK and Switzerland have found out how the coronavirus affects the human brain.

The infection does not cause neuronal death, but provokes inflammatory reactions that can explain neurological symptoms, a study published in the bioRxiv preprint repository noted.

The scientists studied the spread and effect of the COVID-19 in the central nervous system (CNS) of K18-hACE2 transgenic mice that expressed the human ACE2 enzyme, a protein that allows coronavirus to enter the cell. One group of rodents was infected with low doses of coronavirus, and another was first infected with the influenza A virus, and then 3 days later with the coronavirus. The third group of animals was used for control. Mice were euthanized 3-7 days after the dose of SARS-CoV-2.

Scientists found that the COVID-19 entered the central nervous system and spread through neurons on the seventh day of infection. First, it affected the olfactory bulb and then penetrated the lower regions of the brain and spinal cord. The virus did not cause nerve cell death, axonal damage or demyelination, but there was an increased activity of the immune cells of the nervous system - macrophages and T cells, which caused moderate inflammation. All this was accompanied by the death of microglial and endothelial cells during apoptosis.

Microgliosis and apoptosis of immune cells indicate that it is microglial cells that may play an important role in the mechanism of development of neurological disorders during prolonged COVID-19.

Scientists have long found that the SARS-CoV-2 coronavirus affects not only the respiratory system but also affects the brain, causing neurological symptoms such as loss of smell and taste, headache, fatigue or more serious complications, such as cerebrovascular disease.